Long intergenic non-protein coding RNA 1165 (LINC01165)

Long intergenic non-protein coding RNA 1165 (LINC01165) is annotated as a long non-coding RNA (lncRNA), specifically a lincRNA, meaning it is a long (>200 nt) RNA transcript located between protein-coding genes and does not encode a protein[1]. There is no currently documented evidence in the scientific literature that specifically defines the biological function, disease association, or drug interactions for LINC01165. Furthermore, LINC01165 is not established as a therapeutic target, receptor, enzyme, transporter, or otherwise in the context of pharmacology or disease biology[1]. There is no evidence that LINC01165 is a therapeutic target; it does not fall into typical druggable categories like receptor, enzyme, transporter, etc. Current data sources lack information on aliases, functions, disease relevance, or associated drugs. Potential confusion: LINC01165 is similar in name to other better-characterized lincRNAs (e.g., LINC01116, which is involved in cancer and is extensively described in the literature[2]), but no such data exists for LINC01165. This name appears to be correctly formatted, but no substantial characterization of this RNA has been published to date. LINC01165 is annotated as a long intergenic non-coding RNA, but there is no current evidence for it being a therapeutic target, having defined molecular functions, biological roles, disease associations, or interacting drugs. Most data sources lack any substantial information on LINC01165, making this entry essentially uncharacterized at this time[1].